Theravance Biopharma Inc
TBPH | NASDAQ
$17.05
$0 (0.00%)
Sep 22, 2026, 9:42 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 53.81M | 114.54M | 105.9M | 29.34M | 13.03M | -58.33M | -56.42M | -49.4M | -45.65M | -44.77M | -55.19M | -60.94M | -67.51M | -74.65M | -92.82M | -110.6M | -170.26M | -199.87M | -239.29M | -265.69M | -264.16M | -274.64M |
Depreciation & Amortization | 3.95M | 2.83M | 3.05M | 3.31M | 3.44M | 3.49M | 3.62M | 4.34M | 4.51M | 4.46M | 4.26M | 4.86M | 5.69M | 6.68M | 7.02M | 7.39M | 8.23M | 8.74M | 9.71M | 8.45M | 7.82M | 7.98M |
Stock-Based Compensation | 19.55M | 18.1M | 18.48M | 19.82M | 20.21M | 21.04M | 21.39M | 21.39M | 22.69M | 23.58M | 25.37M | 26.5M | 28.77M | 32.21M | 39.73M | 49.7M | 55.54M | 60.77M | 62.06M | 45.14M | 46.34M | 31.4M |
Other Working Capital | 141.39M | 303.83M | 305.17M | 157.4M | 180.9M | 18.13M | 20.57M | 3.23M | 449K | -3.31M | -7.66M | 60.98M | 45.56M | 47.57M | 46.68M | -21.02M | -9.35M | -27.82M | -39.69M | -50.07M | -53.18M | -45.01M |
Other Non-Cash Items | -266.16M | -332.44M | -331.88M | 2.63M | 4.1M | 7.07M | 7.09M | 10.12M | 8.7M | 6.96M | 6.91M | -175.25M | -177.55M | -184.97M | -183.28M | -27.14M | -4.99M | -1.44M | 1.08M | 29.98M | 5.14M | 15.23M |
Deferred Income Tax | -2.19M | -12.67M | -11.52M | -18.14M | -19.04M | -8.91M | -7.57M | -984K | -1.07M | -513K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 242.87M | 478.42M | 454.52M | 206.74M | 223.28M | 68.17M | 20.36M | 3.05M | 2.05M | -6.51M | -8.34M | 54.63M | 40.75M | 48.59M | 42.35M | -24.72M | -17.2M | -32.26M | -41.42M | -48.23M | -57.07M | -45.13M |
Operating Cash Flow | 51.83M | 268.78M | 238.54M | 243.7M | 245.02M | 32.53M | -11.54M | -11.49M | -8.78M | -16.8M | -27M | -150.2M | -169.85M | -172.14M | -186.99M | -105.37M | -128.68M | -164.06M | -207.86M | -230.35M | -261.93M | -265.17M |
Capital Expenditures | -8K | -42K | -42K | -224K | -239K | -241K | -332K | -819K | -825K | -1.64M | -2.49M | -2.08M | -2M | -1.26M | -572K | -750K | -1.85M | -1.89M | -3.41M | -4.21M | -5.22M | -7.43M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 64K | 64K | 64K |
Purchase of Investments | -334.98M | -289.66M | -248.22M | -223.3M | -143.44M | -118.1M | -143.04M | -103.02M | -58.14M | -26.9M | -134.53M | -144.42M | -183.92M | -219.5M | -103.15M | -146.79M | -172.05M | -176.44M | -158.31M | -169.21M | -161.51M | -337.25M |
Sales Maturities Of Investments | 227.52M | 206.38M | 142.98M | 133.34M | 136.34M | 144.23M | 155.65M | 99.76M | 72.26M | 54.62M | 102.81M | 152.12M | 169.13M | 201.73M | 158.02M | 173.5M | 186.5M | 219.2M | 286.2M | 339.41M | 435.03M | 400.63M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.3M | 1.51M | 1.51M | 1.1B | 1.1B | 1.1B | 1.1B | 1.87M | 1.86M | 6K | 6K | 34K | 34K |
Investing Cash Flow | -107.47M | -83.32M | -105.28M | -90.19M | -7.34M | 25.89M | 12.28M | -4.08M | 13.3M | 27.38M | -32.7M | 7.14M | 1.08B | 1.08B | 1.15B | 1.13B | 14.47M | 42.72M | 124.49M | 166.07M | 268.41M | 56.05M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -631.6M | -631.6M | -631.6M | -631.6M | n/a | -5.03M | -10.73M | -10.73M | -10.73M | -5.96M |
Common Stock Repurchased | -2.66M | -8.98M | -4.03M | -2.58M | -2.3M | -2.26M | -3.1M | -33.36M | -64.36M | -145.03M | -199.55M | -204.56M | -267.85M | -187.07M | -132.28M | -96.95M | -4.54M | -4.92M | -9.06M | -9.42M | -8.12M | -8.54M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -967K | n/a | n/a | 133K | 133K | 508K | 508K | 548K | 547K | 618K | 618K | 759K | 5.04M | 5.08M | 5.08M | 5.37M | 1.09M | 3.47M | 3.47M | 4.02M | 4.05M | 3.73M |
Financial Cash Flow | -2.86M | -7.97M | -3.25M | -2.12M | -2.09M | -1.64M | -2.5M | -32.74M | -63.77M | -144.41M | -198.93M | -203.8M | -894.42M | -813.6M | -758.81M | -723.19M | -3.45M | 101.7M | 91.86M | 92.45M | 93.78M | -9.64M |
Net Cash Flow | -58.5M | 177.49M | 130.01M | 151.4M | 235.58M | 56.78M | -1.75M | -48.31M | -59.25M | -133.83M | -258.63M | -346.85M | 18.3M | 93.3M | 208.21M | 297.12M | -117.65M | -19.64M | 8.5M | 28.14M | 100.21M | -218.79M |
Free Cash Flow | 51.82M | 268.74M | 238.5M | 243.48M | 244.78M | 32.29M | -11.87M | -12.31M | -9.6M | -18.44M | -29.49M | -152.28M | -171.85M | -173.4M | -187.56M | -106.12M | -130.53M | -165.95M | -211.26M | -234.56M | -267.15M | -272.6M |
Adj. Free Cash Flow | 32.27M | 250.64M | 220.02M | 223.66M | 224.57M | 11.24M | -33.26M | -33.7M | -32.29M | -42.02M | -54.86M | -178.77M | -200.61M | -205.61M | -227.3M | -155.82M | -186.07M | -226.73M | -273.33M | -279.7M | -313.49M | -303.99M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -938K | -1.2M | -1.15M | -1.26M | -572K | -750K | -1.85M | -1.89M | -3.41M | -4.21M | -3.17M | -5.38M |
Growth CapEx | -8K | -42K | -42K | -224K | -239K | -241K | -332K | -819K | -825K | -1.64M | -1.55M | -873K | -852K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.05M | -2.05M |
Owner Earnings | 51.83M | 268.78M | 238.54M | 243.7M | 245.02M | 32.53M | -11.54M | -11.49M | -8.78M | -16.8M | -27.94M | -151.4M | -171M | -173.4M | -187.56M | -106.12M | -130.53M | -165.95M | -211.26M | -234.56M | -265.1M | -270.55M |
Add to Watchlist
Select watchlists to add or remove TBPH